Geode Capital Management’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.9K | Sell |
190,557
-5,660
| -3% | -$2.91K | ﹤0.01% | 4067 |
|
|
2025
Q1 | $247K | Buy |
196,217
+24,644
| +14% | +$31.1K | ﹤0.01% | 3776 |
|
|
2024
Q4 | $235K | Sell |
171,573
-688
| -0.4% | -$943 | ﹤0.01% | 3852 |
|
|
2024
Q3 | $372K | Buy |
172,261
+21,527
| +14% | +$46.5K | ﹤0.01% | 3697 |
|
|
2024
Q2 | $573K | Buy |
150,734
+19,828
| +15% | +$75.4K | ﹤0.01% | 3519 |
|
|
2024
Q1 | $407K | Buy |
130,906
+17,277
| +15% | +$53.7K | ﹤0.01% | 3686 |
|
|
2023
Q4 | $377K | Hold |
113,629
| – | – | ﹤0.01% | 3720 |
|
|
2023
Q3 | $247K | Buy |
113,629
+16,444
| +17% | +$35.8K | ﹤0.01% | 3897 |
|
|
2023
Q2 | $400K | Hold |
97,185
| – | – | ﹤0.01% | 3734 |
|
|
2023
Q1 | $501K | Hold |
97,185
| – | – | ﹤0.01% | 3649 |
|
|
2022
Q4 | $573K | Buy |
97,185
+2,653
| +3% | +$15.6K | ﹤0.01% | 3602 |
|
|
2022
Q3 | $905K | Buy |
94,532
+21,083
| +29% | +$202K | ﹤0.01% | 3438 |
|
|
2022
Q2 | $758K | Buy |
73,449
+2,183
| +3% | +$22.5K | ﹤0.01% | 3541 |
|
|
2022
Q1 | $962K | Buy |
71,266
+8,049
| +13% | +$109K | ﹤0.01% | 3634 |
|
|
2021
Q4 | $1.03M | Buy |
63,217
+41,578
| +192% | +$679K | ﹤0.01% | 3705 |
|
|
2021
Q3 | $385K | Buy |
+21,639
| New | +$385K | ﹤0.01% | 4151 |
|